Xcel Brands Announces 1-for-10 Reverse Stock Split, Effective March 25

India, March 21 -- Xcel Brands, Inc. (XELB) will implement a 1-for-10 reverse stock split of its outstanding common stock, effective at the start of trading on March 25, 2025. The company's stock wil... Read More

Eurozone Consumer Confidence Unexpectedly Weakens To 3-Month Low

India, March 21 -- Pessimism among Euro area households increased in March as the consumer sentiment measure unexpectedly sunk to its lowest level in three months, preliminary survey data from the Eur... Read More

TransCode Therapeutics Stock Surges 85%

India, March 21 -- TransCode Therapeutics, Inc. (RNAZ) is trading at $1.35, up 77.39 percent or $0.58 during Friday's trading, despite no apparent news driving the movement. The stock opened at $1.01... Read More

Sensex, Nifty Modestly Higher; IT Stocks Drag On Accenture's Warning

India, March 21 -- Indian shares were slightly higher on Friday after opening on a subdued note due to muted global cues. The benchmark S&P/BSE Sensex was up 224 points, or 0.3 percent, at 76,572 in ... Read More

Glenmark Gets FDA Approval For Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)

India, March 20 -- Glenmark Pharmaceuticals Inc., USA announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its Olopatadine Hydrochloride Ophthalmic Solution... Read More

Titan Machinery Stock Rises 12% Despite Reporting Q4 Loss

India, March 20 -- Titan Machinery Inc. (TITN) is trading at $16.55, up 12.36 percent or $1.82 during Thursday's trading, following the release of its fourth-quarter fiscal 2025 results, which reveale... Read More

FDA Approves Alnylam's RNAi Therapeutic AMVUTTRA For ATTR-CM Treatment In Adults

India, March 20 -- Alnylam Pharmaceuticals Inc. (ALNY) announced that the U.S. Food and Drug Administration approved the supplemental New Drug Application (sNDA) for its RNAi therapeutic, AMVUTTRA (vu... Read More

J&J : FDA Approves TREMFYA For Adult Patients With Moderately To Severely Active Crohn's Disease

India, March 20 -- Johnson & Johnson (JNJ) announced that the U.S. Food and Drug Administration has approved TREMFYA (guselkumab), the first and only IL-23 inhibitor offering both subcutaneous (SC) an... Read More

U.S. Leading Economic Index Falls Slightly More Than Expected In February

India, March 20 -- A report released by the Conference Board on Thursday showed its reading on leading U.S. economic indicators fell by slightly more than expected in the month of February. The Confe... Read More

U.S. Stocks Move Mostly Higher After Initial Pullback

India, March 20 -- Stocks moved to the downside at the start of trading on Thursday but have shown a notable turnaround since then. The major averages have climbed well off their lows of the session a... Read More

• ««
• «
• 455
• 456
• 457
• 458
• 459
• 460
• 461
• 462
• 463
• 464
• »
• »»